Paul L. Boyer
Staff Scientist
Center for Cancer Research
National Cancer Institute
United States of America
Biography
Dr. Paul Boyer obtained his Ph.D. in Biochemistry at Michigan State University in 1988. After postdoctoral training in the ABL-Basic Research Program at the NCI-Frederick Cancer Research and Development Center, he was promoted to a Scientist Associate in 1997. Dr. Boyer joined the HIV Drug Resistance Program, National Cancer Institute, as a Staff Scientist in 1998.
Research Interest
identification and characterization of HIV-1 inhibitors, reverse transcriptase
Publications
-
Boyer PL, Clark PK, Hughes SH. HIV-1 and HIV-2 reverse transcriptases: different mechanisms of resistance to nucleoside reverse transcriptase inhibitors. Journal of virology. 2012 May 15;86(10):5885-94.
-
Dunn LL, Boyer PL, Clark PK, Hughes SH. Mutations in HIV-1 reverse transcriptase cause misfolding and miscleavage by the viral protease. Virology. 2013 Sep 30;444(1):241-9.
-
Ivetac A, Swift SE, Boyer PL, Diaz A, Naughton J, Young JA, Hughes SH, McCammon JA. Discovery of Novel Inhibitors of HIVâ€1 Reverse Transcriptase Through Virtual Screening of Experimental and Theoretical Ensembles. Chemical biology & drug design. 2014 May 1;83(5):521-31.
